ולטרקס טבליות 500 מג

البلد: إسرائيل

اللغة: العبرية

المصدر: Ministry of Health

العنصر النشط:

VALACICLOVIR AS HYDROCHLORIDE

متاح من:

GLAXO SMITH KLINE (ISRAEL) LTD

ATC رمز:

J05AB11

الشكل الصيدلاني:

טבליות מצופות פילם

تركيب:

VALACICLOVIR AS HYDROCHLORIDE 500 MG

طريقة التعاطي:

פומי

نوع الوصفة الطبية :

מרשם נדרש

المصنعة من قبل:

GLAXO WELLCOME SA, SPAIN

المجموعة العلاجية:

VALACICLOVIR

المجال العلاجي:

VALACICLOVIR

الخصائص العلاجية:

Valtrex is indicated for the treatment of herpes zoster (shingles) in immunocopotent adults.Valtrex accelerates the resolution of pain, it reduces the duration, and the proportion of patients with zoster-associated pain, which includes acute and post-herpetic neuralgia. The efficacy of valaciclovir in immunocompromised patients has not been established. Valtrex is indicated for the treatment of the initial and recurrent genital herpes due to herpes simplex infection. Valtrex is indicated for the prevention (suppression) of recurrent herpes simplex infections (herpes genitalis). Prophylaxis of cytomegalovirus infection and disease, following organ transplantation. For the treatment of cold sores (herpes labialis).

ملخص المنتج:

התרופה תינתן למניעת מחלת CMV במושתלי איברים

تاريخ الترخيص:

2021-02-28

نشرة المعلومات

" (
)
-
1986
500
"
500
(
) "
VALACICLOVIR (AS HYDROCHLORIDE)
500
MG
6
.
.
.
,
.
.
.
.
1
.
?
)
HSV
) ,(
VZV
(
-
)
CMV
.(
:
•
.
•
VZV
)
ophthalmic zoster
(
.
•
)
HSV
(
)
(
.
.
•
)
HSV
. (
•
CMV
.
:
.
2
.
:
()
)
6
.(
: ,
•
.
•
.
•
65
.
•
.
-
:
)
DRESS
(
.
DRESS
,
. (
)
← ,
. , . , , .
. / , , , . ,
: .
,
,
, ,
. , , , , ,
.
,
,
,
.
.
)
.(
3
.
?
.
.
.
:
)
zoster
s
Herpe
(
•
1,000
)
"
500
,("
.
•
.
)
sores
Cold
)
(
12
(
•
2,000
) "
500
. ,("
•
12
)
6
. (
•
. (
)
HSV
)
12
(
•
500
. ,"
•
.
3
5
.
HSV
)
12
(
•
500
.
,"
•
.
CMV
)
-
)
(
12
(
•
2,000
) "
500
,("
.
•
6
.
•
.
•
90
,
.
:
•
65
.
•
.
•
.
←
.
.
:
•
.
•
.
•
.//
•
.
•
.
65
.
.
.
.
,
.
,
, , ,
. ,
,
,
,
.
, .
,
. ,
.
. ! .
.
. ,
4
.
,
.
. .
:
←
:
.
.(
)
:
•
,
•
()
, , ,
•
.
) ,
.
DRESS
(
. ,
:
)
COMMON
VERY
(
-
:
•
)
COMMON
(
-
-
10
-
1
100
:
•
•
•
•
•
(
)
•
•
)
UNCOMMON
(
-
-
10
-
1
1,000
:
•
•
()
•
•
•
,
,
,
-
8
.
.
:
•
()
•
•
, ,
(
)
•
( )
•
()
:
•
(
)
•
(
)
•
)
RE
RA
(
-
-
10
-
1
10,000
:
•
()
•
() ,
•
()
•
()
•
()
•
()
,
,
,
-
8
.
.
:
•
)
(
:
•
DRESS
,
,
,
,()
,
.
2
.
•
(tubulointerstitial nephritis) ,
. ,
"
"
)
www.health.gov.il
" ,
(
:
https://sideeffects.health.gov.il/
5
.
?
•
!
.
/
.
•
)
exp. date
(
.
.
•
-
C
30°
.
6
.
• ,
:
Microcrystalline cellulose
Crospovidone
Povidone ,K90
White Colour Concentrate YS-
18043
-
1
(Hypromellose, Titanium dioxide, Polysorbate 80, Polyethylene Glycol
400)
Magnesium stearate
Colloidal Anhydrous Silica
Carnauba wax.
•
:
.
500
"
2
,
10
42
.
-
"
GX CF1
"
.
.
•
:
S.A.
.
, ,
•
:
' ," (
)
25
. ,
•
:
100-39-28426-00
.
,
.
,
.
GSK
.
©
2023
GSK
.
2023
.
Val PT v9A